Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women

IMPORTANCE: Endometrial carcinoma (EC) is the most commonly diagnosed gynecologic cancer. Its early detection is advisable because 20% of women have advanced disease at the time of diagnosis. OBJECTIVE: To clinically validate a metabolomics-based classification algorithm as a screening test for EC....

Descripción completa

Detalles Bibliográficos
Autores principales: Troisi, Jacopo, Raffone, Antonio, Travaglino, Antonio, Belli, Gaetano, Belli, Carmen, Anand, Santosh, Giugliano, Luigi, Cavallo, Pierpaolo, Scala, Giovanni, Symes, Steven, Richards, Sean, Adair, David, Fasano, Alessio, Bottigliero, Vincenzo, Guida, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522698/
https://www.ncbi.nlm.nih.gov/pubmed/32986110
http://dx.doi.org/10.1001/jamanetworkopen.2020.18327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522698/
https://www.ncbi.nlm.nih.gov/pubmed/32986110
http://dx.doi.org/10.1001/jamanetworkopen.2020.18327

Ejemplares similares